Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound

[1]  Qi Wei,et al.  Artificial intelligence in medical imaging of the liver , 2019, World journal of gastroenterology.

[2]  Wenquan Feng,et al.  AlphaMEX: A smarter global pooling method for convolutional neural networks , 2018, Neurocomputing.

[3]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[4]  T. Luedde,et al.  IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies , 2018, International journal of molecular sciences.

[5]  Jie Tian,et al.  Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study , 2018, Gut.

[6]  D. Dong,et al.  A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy , 2018, Clinical Cancer Research.

[7]  Aaron C. Abajian,et al.  Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept. , 2018, Journal of vascular and interventional radiology : JVIR.

[8]  Daniel S. Kermany,et al.  Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning , 2018, Cell.

[9]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[10]  Andriy Fedorov,et al.  Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.

[11]  Casey N. Ta,et al.  Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings. , 2017, Radiology.

[12]  Zhenchao Tang,et al.  Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer , 2017, Clinical Cancer Research.

[13]  D. Stocken,et al.  Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. , 2017, The lancet. Gastroenterology & hepatology.

[14]  Peter Schmid,et al.  Abstract 104: miRNAs in the 14q32 cluster are involved in lapatinib resistance , 2017 .

[15]  T. Vogl,et al.  Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy , 2017, CardioVascular and Interventional Radiology.

[16]  D. Mitchell,et al.  Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR) , 2017, Ultraschall in der Medizin - European Journal of Ultrasound.

[17]  Ramprasaath R. Selvaraju,et al.  Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization , 2016, International Journal of Computer Vision.

[18]  François Chollet,et al.  Xception: Deep Learning with Depthwise Separable Convolutions , 2016, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[19]  Yanqi Huang,et al.  Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Luc Van Gool,et al.  Temporal Segment Networks: Towards Good Practices for Deep Action Recognition , 2016, ECCV.

[21]  R. Lencioni,et al.  Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data , 2016, Hepatology.

[22]  Myeong-Jin Kim,et al.  Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. , 2015, Journal of hepatology.

[23]  Geoffrey E. Hinton,et al.  Deep Learning , 2015, Nature.

[24]  M. Kudo,et al.  Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[25]  Ming-de Lu,et al.  Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST , 2015, European Radiology.

[26]  Nitish Srivastava,et al.  Unsupervised Learning of Video Representations using LSTMs , 2015, ICML.

[27]  Lorenzo Torresani,et al.  Learning Spatiotemporal Features with 3D Convolutional Networks , 2014, 2015 IEEE International Conference on Computer Vision (ICCV).

[28]  H. Heinzl,et al.  How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma. , 2014, Journal of hepatology.

[29]  Mohammad Eghtedari,et al.  2-Tier In-Plane Motion Correction and Out-of-Plane Motion Filtering for Contrast-Enhanced Ultrasound , 2014, Investigative radiology.

[30]  Ewout Steyerberg,et al.  Net Reclassification Improvement: Computation, Interpretation, and Controversies , 2014, Annals of Internal Medicine.

[31]  B. Morgan,et al.  Contrast‐enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[32]  A. Burroughs,et al.  A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  H. Heinzl,et al.  The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma , 2013, Hepatology.

[34]  Myeong-Jin Kim,et al.  Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation. , 2013, European journal of cancer.

[35]  W. Lau,et al.  Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  I. Kamel,et al.  Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment? , 2012, Radiology.

[37]  K. Stamatiou,et al.  Hepatocellular carcinoma treated with transarterial chemoembolization: Evaluation with parametric contrast-enhanced ultrasonography. , 2012, World journal of radiology.

[38]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[39]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[40]  Richard Simon,et al.  Bias in error estimation when using cross-validation for model selection , 2006, BMC Bioinformatics.

[41]  J. Bruix,et al.  Chemoembolization for hepatocellular carcinoma. , 2004, Gastroenterology.

[42]  K. Okuda,et al.  Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma , 2003, Cancer.

[43]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[44]  J. Friedman.  Greedy function approximation: A gradient boosting machine. , 2001 .

[45]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[46]  K Arai,et al.  Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. , 1993, Radiology.

[47]  M. Pencina,et al.  Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. , 2014, Annals of internal medicine.

[48]  Y. Rolland,et al.  Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma , 2012, Cancer.

[49]  O. Matsui,et al.  Treatment with Subsegmental Transcatheter Arterial Embolization for Hepatocellular Carcinoma: Prognosis, Recurrence, and Effect on Liver Function , 2000 .